Clinical trial
Gene Modifiers of Cystic Fibrosis Lung Disease
NCT00037765 · University of North Carolina, Chapel Hill, Other · Active, not recruiting
Key facts
| NCT number | NCT00037765 |
|---|---|
| Title | Gene Modifiers of Cystic Fibrosis Lung Disease |
| Official title | Gene Modifiers of Cystic Fibrosis Lung Disease |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Cystic Fibrosis, Lung Diseases |
| Enrollment | 600 |
| Start date | Sep 1, 2001 |
| Primary completion | Jul 1, 2027 |
| Completion | Jul 1, 2027 |
| First posted | May 21, 2002 |
| Last update posted | Sep 23, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: